Clinical Trial Update: First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

A first-in-human study of ADCE-D01 in soft tissue sarcoma (metastatic or unresectable) is in Phase 1/2 and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• ADCE-D01

Snippet

Sponsor: Adcendo ApS | Conditions: Metastatic Soft Tissue Sarcoma, Unresectable Soft Tissue Sarcoma | Phase 1, Phase 2 | Status: RECRUITING